ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

6,793Medicare Part D Prescriptions Filled, Including Refills

Rank: 40 out of 717

$555K Total Retail Price of All Prescriptions

Rank: 67 out of 717

274 Patients Receiving at Least One Drug in Part D
92%Patients 65 Years and Older
34% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 274 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,335 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 0%.

Brand Name Drugs

49% of this provider’s prescriptions were for brand-name drugs, compared to an average of 33%.

Prescription Price

$82 was the average price of a prescription from this provider, compared to $88 among peers.

Prescriptions per Patient

25 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
BYSTOLIC 327 319 1 29
SIMVASTATIN 280 253 2 3
ATORVASTATIN CALCIUM 274 259 3 4
METOPROLOL SUCCINATE 268 203 4 1
FUROSEMIDE 226 213 5 5
AMLODIPINE BESYLATE 213 195 6 2
CARVEDILOL 188 172 7 6
METFORMIN HCL 160 147 8 30
BENICAR 153 129 9 68
LIPITOR 144 138 10 19
LEVOTHYROXINE SODIUM 123 119 11 23
DONEPEZIL HCL 120 120 12 57
LOVAZA 116 116 13 33
NAMENDA 103 103 14 78
BENICAR HCT 101 101 15 79
TAMSULOSIN HCL 100 84 16 70
WARFARIN SODIUM 95 95 17 7
ATENOLOL 94 91 18 18
CLOPIDOGREL 91 88 19 10
CRESTOR 89 66 20 11
DIOVAN 89 83 20 13
POTASSIUM CHLORIDE 88 84 22 27
PANTOPRAZOLE SODIUM 81 65 23 49
LISINOPRIL 74 59 24 9
NEXIUM 73 60 25 37
DIGOXIN 73 73 25 14
PLAVIX 67 59 27 12
PRADAXA 65 59 28 22
HYDROCHLOROTHIAZIDE 64 60 29 17
SERTRALINE HCL 59 47 30 81
OMEPRAZOLE 57 54 31 28
LOSARTAN POTASSIUM 56 56 32 16
GLIMEPIRIDE 55 55 33 59
ZOLPIDEM TARTRATE 55 43 33 35
ONGLYZA 53 53 35 186
CYMBALTA 52 47 36 131
METOPROLOL TARTRATE 52 50 36 8
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 5, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.